Carglumic acid

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68475-006
  • Package NDC 68475-006-01
  • Package NDC 68475-006-02
  • Application number ANDA213395
  • SPL ID 55e79bd0-56bd-4095-aa7e-942b3e5c1b40
  • SPL set ID 59e73eb8-edf8-4fad-93c2-deb6b23497f8
  • UNII 5L0HB4V1EW
  • RxCUI 905390

What the source publishes

Labeler
Navinta LLC
Active ingredients
Carglumic acid
Form
TABLET, FOR SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68475-006_55e79bd0-56bd-4095-aa7e-942b3e5c1b40
{
  "name": "Carglumic acid",
  "splId": "55e79bd0-56bd-4095-aa7e-942b3e5c1b40",
  "labels": [
    {
      "setId": "59e73eb8-edf8-4fad-93c2-deb6b23497f8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59e73eb8-edf8-4fad-93c2-deb6b23497f8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59e73eb8-edf8-4fad-93c2-deb6b23497f8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Navinta LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "5 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-01)",
      "package_ndc": "68475-006-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220801"
    },
    {
      "sample": false,
      "description": "60 TABLET, FOR SUSPENSION in 1 BOTTLE (68475-006-02)",
      "package_ndc": "68475-006-02",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220801"
    }
  ],
  "productId": "68475-006_55e79bd0-56bd-4095-aa7e-942b3e5c1b40",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FOR SUSPENSION",
  "productNdc": "68475-006",
  "deaSchedule": null,
  "genericName": "Carglumic acid",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CARGLUMIC ACID",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "ANDA213395",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220801",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000184144",
      "N0000184143"
    ],
    "unii": [
      "5L0HB4V1EW"
    ],
    "rxcui": [
      "905390"
    ],
    "spl_set_id": [
      "59e73eb8-edf8-4fad-93c2-deb6b23497f8"
    ],
    "pharm_class_epc": [
      "Carbamoyl Phosphate Synthetase 1 Activator [EPC]"
    ],
    "pharm_class_moa": [
      "Carbamoyl Phosphate Synthetase 1 Activators [MoA]"
    ],
    "manufacturer_name": [
      "Navinta LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68475-006_55e79bd0-56bd-4095-aa7e-942b3e5c1b40"